pradaxa | Law Firm Newswire

Rockville Centre, NY (Law Firm Newswire) August 29, 2014 – A new study shows that physicians are prescribing Pradaxa, Xarelto, and Apixaban in higher numbers than ever, notwithstanding research linking these blood-thinning drugs to potentially fatal adverse side effects. According to an analysis published in the American Journal of Medicine, physicians have been prescribing newer anticoagulants such as Pradaxa, Xarelto, and Apixaban to treat patients with atrial fibrillation, instead of older drugs such as the popular warfarin. An editorial that accompanies the study acknowledges that “there is no antidote to reverse the anticoagulant effect with these new drugs in the […]


Continue reading full article »

Rockville Centre, NY (Law Firm Newswire) August 18, 2014 – The Rottenstein Law Group, a national personal injury law firm that represents persons who believe they were injured by anticoagulants such as Pradaxa and Xarelto (www.xareltoinjuryfirm.com), has learned that Pradaxa manufacturer Boehringer Ingelheim has suffered a 5% drop in sales in the first half of 2014. According to FiercePharma, “The Germany-based company forecasts revenues will be down for the year as well, but it says by getting its house in order, its finances can improve after that. It has settled some nagging litigation and sold some assets, and it’s about […]


Continue reading full article »